Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in Phase I/II dose escalation trial in patients with solid tumor cancers, including non-small-cell lung (NSCLC), gastric, head and neck, ovarian, and synovial sarcoma cancers; IMC-F106C, which is in a Phase I/II dose escalation trial in patients with multiple solid tumor cancers comprising NSCLC, small-cell lung, endometrial, ovarian, cutaneous melanoma, and breast cancers. In addition, the company's programs for infectious diseases include IMC-I109V, which is in a Phase I/II clinical trial in patients with chronic hepatitis B virus; and IMC-M113V that is in pre-clinical development stage for patients with human immunosuppression virus. Further, it develops product candidates to provide precision targeted immunosuppression for the treatment of autoimmune diseases. Immunocore Holdings plc was founded in 1999 and is headquartered in Abingdon, the United Kingdom.

Immunocore Holdings plc

Immunocore is a leading T cell receptor (TCR) biotechnology company working to create first-in-class biological therapies to address unmet patient needs in oncology as well as infectious and autoimmune diseases. 

See our community guidelines: http://bit.ly/2kFA8hr

Oxford Finance LLC

General Atlantic

Rock Springs Capital

RTW Investments

WuXi AppTec

Bill & Melinda Gates Foundation

Terra Magnum Capital Partners (""""TMCP"""")""

CCB International

JDRF T1D Fund

BlackRock

Immunocore

Unhealthy cells have evolved mechanisms for evading T cells, making diseases like cancer harder to treat. 

ImmTAC molecules contain a T cell receptor that has been engineered to better recognise its target and seek out evading cells. #IMCRSharing #innovation

It is by living our values daily that we are able to develop transformative treatments and to innovate for patients. #WeAreIMCR #innovation #ResearchAndDevelopment

Looking to advance your career in Regulatory Affairs? Apply for our Regulatory Submissions Manager position and grow within a highly innovative, agile, and entrepreneurial environment. https://lnkd.in/eu7WxW_v #WeAreIMCR #hiring #biotechjobs

Gynecologic cancers account for nearly 40% of cancer cases & 1/3 of cancer deaths in women. We must continue the search for new treatments & prevention measures to save the lives of women across the globe. #CervicalCancerPreventionWeek #CervicalCancerAwarenessMonth #WeAreIMCR

Come and apply the principles of effective clinical project practices at a pioneering biotech. #WeAreIMCR #biotechjobs #hiring
https://lnkd.in/eTSVJJcC

Filer	Shares	Latest Filing Date	Previously owned	Change	Share-Type	Market Value
Rock Springs Capital Manage...	3.03M	2023-08-14	3.00M	26.75K	Shares	181.58M
Baker Bros. Advisors Lp	2.52M	2023-08-14	2.52M	0	Shares	151.14M
Baker Bros. Advisors Lp	2.52M	2021-05-17	0	2.52M	Shares	107.31M
Rock Springs Capital Manage...	2.29M	2021-05-17	0	2.29M	Shares	97.58M
Fmr Llc	1.42M	2021-05-14	0	1.42M	Shares	60.50M
Rtw Investments, Lp	1.25M	2021-05-14	0	1.25M	Shares	50.14M
Blackrock Inc.	1.08M	2021-05-07	0	1.08M	Shares	45.98M
General Atlantic, L.P.	950K	2023-08-11	950K	0	Shares	56.96M
General Atlantic, L.P.	950K	2021-05-17	0	950K	Shares	40.44M
Bill & Melinda Gates Founda...	576.92K	2021-11-15	0	576.92K	Shares	24.56M
Bill & Melinda Gates Founda...	576.92K	2023-08-14	576.92K	0	Shares	34.59M
Avidity Partners Management Lp	575K	2023-08-14	769.80K	-194.80K	Shares	34.48M
Avidity Partners Management Lp	550K	2021-05-17	0	550K	Shares	23.41M
Perceptive Advisors Llc	400K	2021-08-13	0	400K	Shares	17.03M
Price T Rowe Associates Inc...	387.91K	2021-05-17	0	387.91K	Shares	16.51M
Thrivent Financial For Luth...	320.25K	2021-05-17	0	320.25K	Shares	13.63M
Bain Capital Public Equity ...	300.87K	2021-05-17	0	300.87K	Shares	12.81M
Great Point Partners Llc	297.08K	2023-08-14	255.37K	41.72K	Shares	17.81M
Hhlr Advisors, Ltd.	279.58K	2021-05-17	0	279.58K	Shares	11.90M
Wellington Management Group...	247.36K	2021-05-17	0	247.36K	Shares	10.53M
Millennium Management Llc	203.66K	2021-05-17	0	203.66K	Shares	8.67M
Artal Group S.A.	200K	2021-05-14	0	200K	Shares	8.51M
Deerfield Management Compan...	171.91K	2021-05-17	0	171.91K	Shares	7.32M
Invesco Ltd.	150.66K	2021-05-17	0	150.66K	Shares	6.41M
Tybourne Capital Management...	138.19K	2021-04-13	0	138.19K	Shares	5.88M
Principal Financial Group Inc	123.57K	2021-05-24	0	123.57K	Shares	5.26M
Massachusetts Financial Ser...	97.50K	2021-05-13	0	97.50K	Shares	4.15M
Samsara Biocapital, Llc	80K	2021-05-18	0	80K	Shares	3.41M
Marshall Wace North America...	61.76K	2021-08-27	0	61.76K	Shares	2.63M
Omega Fund Management, Llc	51.53K	2021-05-17	0	51.53K	Shares	2.19M
Citadel Advisors Llc	51.44K	2021-05-21	0	51.44K	Shares	2.19M
Sphera Funds Management Ltd.	36K	2021-05-17	0	36K	Shares	1.53M
Alyeska Investment Group, L.P.	35K	2021-05-17	0	35K	Shares	1.49M
Td Asset Management Inc	27.51K	2021-05-14	0	27.51K	Shares	1.17M
Advisory Research Inc	24.46K	2023-08-14	20.39K	4.07K	Shares	1.47M
Legal & General Group Plc	23.97K	2023-08-14	6.05K	17.92K	Shares	1.44M
Eschler Asset Management Llp	20K	2022-11-14	0	20K	Shares	939K
Pinz Capital Management, Lp	18.70K	2021-05-17	0	18.70K	Shares	796K
Morgan Stanley	15.21K	2021-05-17	0	15.21K	Shares	648K
Caas Capital Management Lp	15K	2021-05-17	0	15K	Shares	639K
Etf Managers Group, Llc	13.21K	2021-05-17	0	13.21K	Shares	571K
Ubs Group Ag	11.67K	2021-05-12	0	11.67K	Shares	497K
Zimmer Partners, Lp	10K	2021-05-17	0	10K	Shares	426K
Anson Funds Management Lp	10K	2021-05-14	0	10K	Shares	426K
Victory Capital Management Inc	10K	2021-05-04	0	10K	Shares	426K
Laurion Capital Management Lp	5K	2021-05-14	0	5K	Shares	213K
Veritas Investment Partners...	575	2023-08-09	575	0	Shares	34.45K
Rokos Capital Management Llp	500	2021-05-13	0	500	Shares	21K
Advisor Group Holdings, Inc.	122	2021-05-13	0	122	Shares	5K
Bank Of America Corp /De/	100	2021-05-14	0	100	Shares	4K
Harbour Investments, Inc.	25	2021-08-17	0	25	Shares	1K
Velan Capital Investment Ma...	0	2023-08-11	200K	-200K	Shares	0
Federated Hermes, Inc.	0	2023-08-14	74.36K	-74.36K	Shares	0
Concourse Financial Group S...	0	2021-05-13	0	0	Shares	0

NASDAQ:IMCR

Immunocore Holdings plc

Last Close

59.46

03/05 20:00

Market Cap

3.46B

Beta: 0.55

Volume Today

374.04K

Avg: 266.28K

PE Ratio

−53.27

PFCF: 257.21

Institutional trades

Institutional Ownership

Current holdings institutionals